Ameritas Investment Partners’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85.2K | Hold |
2,604
| – | – | ﹤0.01% | 1943 |
|
|
2026
Q1 | $92.1K | Hold |
2,604
| – | – | ﹤0.01% | 1738 |
|
|
2025
Q4 | $106K | Hold |
2,604
| – | – | ﹤0.01% | 1660 |
|
|
2025
Q3 | $122K | Sell |
2,604
-624
| -19% | -$32.4K | ﹤0.01% | 1558 |
|
|
2025
Q2 | $168K | Hold |
3,228
| – | – | 0.01% | 1408 |
|
|
2025
Q1 | $195K | Hold |
3,228
| – | – | 0.01% | 1275 |
|
|
2024
Q4 | $221K | Buy |
3,228
+205
| +7% | +$14.3K | 0.01% | 1263 |
|
|
2024
Q3 | $217K | Hold |
3,023
| – | – | 0.01% | 1256 |
|
|
2024
Q2 | $210K | Sell |
3,023
-152
| -5% | -$11.1K | 0.01% | 1236 |
|
|
2024
Q1 | $254K | Hold |
3,175
| – | – | 0.01% | 1129 |
|
|
2023
Q4 | $348K | Buy |
3,175
+128
| +4% | +$13.2K | 0.01% | 943 |
|
|
2023
Q3 | $307K | Buy |
3,047
+514
| +20% | +$59.1K | 0.01% | 946 |
|
|
2023
Q2 | $344K | Buy |
2,533
+250
| +11% | +$30.5K | 0.01% | 885 |
|
|
2023
Q1 | $237K | Hold |
2,283
| – | – | 0.01% | 997 |
|
|
2022
Q4 | $226K | Hold |
2,283
| – | – | 0.01% | 1064 |
|
|
2022
Q3 | $183K | Buy |
2,283
+167
| +8% | +$15.8K | 0.01% | 1105 |
|
|
2022
Q2 | $202K | Sell |
2,116
-161
| -7% | -$19.3K | 0.01% | 1061 |
|
|
2022
Q1 | $338K | Hold |
2,277
| – | – | 0.01% | 920 |
|
|
2021
Q4 | $323K | Hold |
2,277
| – | – | 0.01% | 944 |
|
|
2021
Q3 | $298K | Hold |
2,277
| – | – | 0.01% | 956 |
|
|
2021
Q2 | $313K | Hold |
2,277
| – | – | 0.01% | 944 |
|
|
2021
Q1 | $297K | Hold |
2,277
| – | – | 0.01% | 951 |
|
|
2020
Q4 | $255K | Sell |
2,277
-117
| -5% | -$11.1K | 0.01% | 1001 |
|
|
2020
Q3 | $188K | Hold |
2,394
| – | – | 0.01% | 1066 |
|
|
2020
Q2 | $172K | Hold |
2,394
| – | – | 0.01% | 1084 |
|
|
2020
Q1 | $137K | Hold |
2,394
| – | – | 0.01% | 1098 |
|
|
2019
Q4 | $268K | Buy |
2,394
+74
| +3% | +$7.89K | 0.01% | 935 |
|
|
2019
Q3 | $223K | Hold |
2,320
| – | – | 0.01% | 995 |
|
|
2019
Q2 | $199K | Buy |
2,320
+234
| +11% | +$19.2K | 0.01% | 1058 |
|
|
2019
Q1 | $174K | Hold |
2,086
| – | – | 0.01% | 1120 |
|
|
2018
Q4 | $134K | Hold |
2,086
| – | – | 0.01% | 1196 |
|
|
2018
Q3 | $165K | Hold |
2,086
| – | – | 0.01% | 1219 |
|
|
2018
Q2 | $153K | Sell |
2,086
-296
| -12% | -$20.1K | 0.01% | 1243 |
|
|
2018
Q1 | $151K | Hold |
2,382
| – | – | 0.01% | 1236 |
|
|
2017
Q4 | $121K | Hold |
2,382
| – | – | 0.01% | 1391 |
|
|
2017
Q3 | $118K | Hold |
2,382
| – | – | 0.01% | 1358 |
|
|
2017
Q2 | $121K | Hold |
2,382
| – | – | 0.01% | 1348 |
|
|
2017
Q1 | $106K | Buy |
+2,382
| New | +$102K | 0.01% | 1397 |
|
Other funds holding CNMD
ICM
Ameritas Investment Partners's CNMD Position: Q2 2026 in Review
Ameritas Investment Partners held its CONMED (CNMD) position steady in Q2 2026 at 2,604 shares worth $85.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.
Ameritas Investment Partners first reported a position in CNMD in Q1 2017 and has held it in 38 quarters since. The position peaked at $348K in Q4 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Ameritas Investment Partners held 2,604 shares of CONMED worth $85.2K as of Q2 2026.
- Ameritas Investment Partners left its CONMED share count unchanged in Q2 2026.
- CONMED made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1943 holding.
- Ameritas Investment Partners first reported a position in CONMED in Q1 2017 and has held it in 38 quarters since.
- Ameritas Investment Partners's CONMED position peaked at $348K in Q4 2023.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.